private
Biotechnology
Common Shares
I am seeking to sell 100,000 common shares in Niihara International ("Niihara") at $2.00/common share. These shares were purchased over one year ago. Niihara is a biotechnology company that is set up to develop and manufacture pharmaceutical products. The company's early focus is on the treatment of Sickle Cell Disease ("SCD"). Currently, the company owns one of the only facilities in the world that can manufacture pharmaceutical grade L-glutamine to treat SCD. The company has leveraged its manufacturing capability to work directly with governments in India, Africa and the Middle East. In addition to manufacturing generic pharmaceuticals, Niihara is also conducting its own research and development for alternative SCD treatments as well as other disease treatments. The company was founded by a leading doctor and medical research professional with over 20 years of experience developing SCD treatments.
Securities to be Sold: | 100,000 Common Shares |
List Price of Securities: | $200,000 |
Borrower’s Estimate of Market Value of Securities | $200,000 |
24 Covered Wagon Ln.
Rolling Hills Estates,
California,
90274
Legal Counsel
This issuer is Second Market Certified with Glass Box, allowing for its shares to be deposited electronically with banks or broker dealers.